Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 3 (3 total).

National Center on Birth Defects and Developmental Disabilities. [2006]. Jaundice alert: What every parent needs to know. Atlanta, GA: National Center on Birth Defects and Developmental Disabilities, 2 pp.

Annotation: This fact sheet for parents of newborn infants provides information about jaundice. It explains what jaundice is and discusses causes, signs, treatment, risk factors, and what parents can do to ensure that an infant's jaundice does not cause brain damage. The fact sheet is printed in English on one side and in Spanish on the other.

Contact: National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: [email protected] Web Site: http://www.cdc.gov/ncbddd Available from the website.

Keywords: Consumer education materials, High risk infants, Infant health, Neonatal jaundice, Newborn infants, Prevention, Spanish language materials, Treatment

Odell GB, Schaffer R, Simopoulos AP, eds. 1974. Phototherapy in the newborn: An overview. Washington, DC: National Academy of Sciences, 190 pp.

Annotation: This volume includes selected papers from a symposium held in Washington, DC, February 12-13, 1973, under the sponsorship of the Committee on Phototherapy in the Newborn. Also provided are additional technical papers prepared by various members of the Committee. It is intended to be of interest to photobiologists, photochemists, bioengineers, physicists, medical researchers, and clinicians. Topics include the use of phototherapy; bilirubin; neonatal hyperbilirubinemia; bilirubin-dependent brain damage; phototherapy and preterm infants; circadian rhythms, and clinical management of infants with hyperbilirubinemia. Reference notes are provided at the end of each paper. [Funded by the Maternal and Child Health Bureau]

Keywords: Conferences, Hyperbilirubinemia, Neonatal jaundice, Neonatal screening, Phototherapy

American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114(1):297-316 July 2004 with Erratum 114(4):1138 October 2004., (Clinical practice guideline)

Annotation: These guidelines provide a framework for the prevention and management of hyperbilirubinemia in newborn infants of 35 or more weeks of gestation to reduce the risk of severe hyperbilirubinemia and bilirubin encephalopathy while minimizing the risks of unintended harm such as maternal anxiety, decreased breastfeeding, and unnecessary costs or treatments. Contents include a definition of recommendations and conditions, a description of the focus of the guideline, primary and secondary prevention, treatment, implementation strategies, and future research needs.

Contact: American Academy of Pediatrics, 345 Park Boulevard, Itasca, IL 60143, Telephone: (630) 626-6000 Secondary Telephone: (847) 434-4000 Fax: (847) 434-8000 Web Site: https://www.aap.org Available from the website.

Keywords: Guidelines, Hyperbilirubinemia, Infant health, Infant health services, Jaundice, Neonatal screening, Pediatric care, Resources for professionals
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.